NEWS FEATURES
2024
2022
Mediphage featured at TEDx Toronto 2022
Mediphage-lead project in collaboration with Ardra receives NGen funding
2021
2020
2019
Mediphage Press Releases & White Papers:
2024
The advantages of linear DNA vs circular DNA plasmids
Mar 13th, 2024
Mediphage Bioceuticals, Inc. Closes Seed Round of Financing
Feb 7th, 2024
2023
Mediphage Signs an Option Agreement with Multinational Big Pharma
Jan 4th, 2023
2021
CCRM Enterprises invests in Mediphage’s novel gene therapy platform
December 16th, 2021
2020
Alvaro Amorrortu Joins as Mediphage’s CEO and President
October 1st, 2020
$215K awarded in Support of COVID-19 Program Hiring Needs
June 15th , 2020
COVID-19 Vaccine Development Program
March 31st, 2020
2019
Establishment of Large-Scale msDNA Production In-House
August 1st, 2019
Closed $3.5M Seed Round of Financing
July 15th, 2019
Dr. Nafiseh Nafissi as Vice President of Research and Development
April 1st, 2019